Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| Market is closed on Tue. Jan. 2, 2024 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) DIA(0%) GDX(0%) GDXJ(0%) GLD(0%) IVE(0%) | Factors Impacting EDIT price | EDIT will advance at least -0% in a week (0% probabilities). XLE(0%) XBI(0%) VXX(0%) VIXM(0%) UUP(0%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |